US Drug and Device Register

What US Drug and Device Register does

US Drug and Device Register (USDDR), based in Scottsdale, Arizona, is a privately held life sciences market access consulting firm that helps manufacturers plan, launch, and scale pharmaceutical, medical device, OTC/consumer health, durable medical equipment, and adjacent-category products in the US healthcare market. Rather than operating a technology platform, the firm delivers an integrated advisory offering organized into 15 modular service lines spanning commercial launch, regulatory and product-identifier readiness (NDC/UDI), institutional access across GPOs/IDNs/hospitals, long-term care access, GPO contract support, federal and military procurement pathways (GSA/FSS, DLA, ECAT, DAPA, IHS), reimbursement and payer strategy, strategic brand consultation, compendia, accreditation, training, compliance, market intelligence, omnichannel/eCommerce, and communication/publication. Clients range from large unnamed global device, med-surg, and CPG manufacturers to smaller pharmaceutical/OTC firms with declining growth curves.

USDDR monetizes through professional-services engagements, including project-based and retainer consulting, rather than software licensing or transaction fees. Pricing is not publicly disclosed and is described as quote-based and engagement-scoped. The go-to-motion combines an inbound digital channel (corporate website and LinkedIn) with what the firm characterizes as enterprise field engagement, scoping 360-degree access programs from regulatory and compliance setup through distribution and channel execution across retail, institutional, payer, LTC, and federal pathways.

Operationally, USDDR is a bootstrap or founder-owned private firm with 1-10 employees, no external funding rounds, no parent company, and no known M&A activity. The firm reports 30+ years of cumulative advisory experience and 280+ product launches supported, which underpins its positioning as the operating link between manufacturers and the stakeholders (payers, providers, GPOs, distributors, institutions) that determine product coverage, placement, and utilization in the US market.

Name

US Drug and Device Register

Legal name

US Drug and Device Register

Website

https://druganddeviceregister.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

1–10 employees

Short description

US Drug and Device Register (USDDR) is a privately held, Scottsdale-based life sciences market access consulting firm that helps pharmaceutical, medical device, OTC, and adjacent manufacturers plan, launch, and scale in the US through 15 modular advisory services spanning regulatory, institutional, payer, federal, and commercial channels.

Ownership category

akta.pro rank

Product category

Life Sciences Market Access Consulting

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK)

akta.pro secondary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Life sciences consulting
• Market access strategy
• Pharmaceutical commercialization
• Regulatory readiness services
• Medical device advisory

Headquarters

HQ city

Scottsdale

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Consulting and Advisory Services: Professional consulting services for life sciences market access, commercialization planning, regulatory compliance, and channel execution. Revenue likely derived from project-based engagements and retainer arrangements with manufacturers seeking US market entry and expansion.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

US Drug and Device Register provides market access and commercialization consulting services to pharmaceutical and medical device manufacturers. The firm delivers approximately fifteen specialized service lines spanning commercial launch support, regulatory readiness, institutional access, long-term care (LTC) channel strategy, Group Purchasing Organization (GPO) contracts, federal and military market access, reimbursement strategy, brand planning, compendia management, accreditation support, training, compliance, market intelligence, omnichannel engagement, and communication services.

Product overview

US Drug and Device Register (USDDR) is a life sciences market access consulting partner that offers a modular set of advisory services organized around helping manufacturers plan, launch, and scale products in the US healthcare market. Rather than a unified software platform, the offering consists of 15 distinct consulting service lines covering Commercial Launch, Regulatory & Product Identifier Readiness, Institutional Market Access, Long-Term Care Access, GPO Contract Support, Federal & Military Access, Reimbursement & Payer Support, Strategic Brand Consultation, Compendia Services, Accreditation, Training & Development, Compliance Support, Market Intelligence, Omnichannel/eCommerce, and Communication & Publication. These services can stand alone or combine into a full 360-degree market access and commercialization program. The company supports life sciences enterprises including pharmaceuticals, digital therapeutics, medical devices, durable medical equipment, consumer health/OTC, and other categories.

Differentiator

Problem solved

Functional benefit

Products and services

• Commercial Launch Support Consulting support for drug and medical device manufacturers preparing for commercial product launches, spanning go-to-market planning and execution.
• Regulatory Readiness Advisory services helping pharmaceutical and medical device manufacturers prepare for regulatory milestones and readiness requirements.
• Institutional Access Consulting services for manufacturers seeking access to institutional healthcare channels such as hospitals and health systems.
• Long-Term Care (LTC) Channel Strategy Advisory services supporting drug and medical device manufacturers entering and operating within the long-term care channel.
• GPO Contracts Consulting support for manufacturers pursuing Group Purchasing Organization contracting strategies and negotiations.
• Federal and Military Market Access Advisory services for manufacturers seeking access to federal and military healthcare channels for drug and medical device products.
• Reimbursement Strategy Consulting services for manufacturers developing reimbursement strategies and engaging with payers to support product access.
• Strategic Brand Planning Advisory services supporting brand strategy and planning for pharmaceutical and medical device manufacturers.
• Compendia Management Consulting support for manufacturers managing drug compendia listings and related references.
• Accreditation Support Advisory services helping manufacturers meet accreditation requirements relevant to drug and medical device commercialization.
• Training Services Training programs for manufacturer teams supporting market access, compliance, and commercialization capabilities.
• Compliance Services Consulting support for manufacturers navigating compliance requirements related to commercialization and market access.
• Market Intelligence Intelligence and research services delivering market insights to drug and medical device manufacturers.
• Omnichannel Engagement Consulting services supporting manufacturers' omnichannel engagement strategies for healthcare audiences.
• Communication Services Communication consulting supporting manufacturers' market access and commercialization messaging strategies.

Quantifiable outcome

• 30+ years of combined experience and 280+ launches supported

Named customers4 records

Segments6 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Syneos Health: Large contract research organization and commercial solutions provider offering clinical, medical affairs, and commercialization services to life sciences manufacturers—broader portfolio but overlapping in commercialization and market access.
• IQVIA: Global leader in life sciences technology, analytics, and consulting, providing market access, commercialization, and R&D services—represents the largest scaled competitor in the same space.
• Parexel International: Global clinical research and biopharmaceutical services provider with commercialization and market access capabilities serving pharma and medical device manufacturers—larger incumbent with overlapping service scope.
• Guidehouse: Management consulting firm with a substantial healthcare and life sciences practice advising on strategy, operations, and compliance—broader than USDDR but competing for similar consulting engagements.

Direct peers

• Blue Fin Group: Life sciences consulting firm focused on commercial strategy, market access, and channel/GTN optimization for pharma and consumer health companies—a similar boutique-style competitor.
• Indegene: Life sciences commercialization partner offering market access, medical affairs, regulatory, and commercial services to pharma, biotech, and medical device companies—competes for the same manufacturers seeking US market entry and scale.
• Trinity Life Sciences: Life sciences strategy and insights consultancy supporting brand commercialization, market access, and evidence generation for pharma and biotech—directly comparable in client base and service focus.
• ZS Associates: Global management consulting and technology firm focused on life sciences, helping pharmaceutical and medical product companies with sales, marketing, market access, and commercialization strategy—directly overlapping with USDDR's core service lines.
• Avalere Health: Healthcare policy and market access consultancy advising life sciences companies on payer strategy, coverage, reimbursement, and evidence—closely matching USDDR's reimbursement and payer access offerings.
• EVERSANA: End-to-end life sciences commercialization services company covering market access, distribution, patient services, and reimbursement—closely paralleling USDDR's integrated commercialization model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/drug-and-device-register
• Xx.com/drug_device

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about US Drug and Device Register